Europe — EMA
Ondansetron Stada
Ondondansetron, the active ingredient in Ondansetron Stada, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use.
Request sourcing
What is Ondansetron?
Ondondansetron, the active ingredient in Ondansetron Stada, is a 5-HT3 receptor antagonist presented as a unknown/unknown for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery in adult and pediatric patients.
GNH USA supplies Ondansetron Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Ondansetron used for?
Ondansetron Stada is a selective 5‑HT3 receptor antagonist that acts on the serotonin pathway to prevent nausea and vomiting. - Chemotherapy‑induced nausea and the C .... - .... ... .... .... ... ....
Product details
Related products
Ondansetron 2 mg/mL
Ondansetron · 2 mg/mL
Ondansetron 2 mg/mL
Ondansetron · 2 mg/mL
Ondansetron 2 mg/mL
Ondansetron · 2 mg/mL
ONDANSETRON 2 mg/mL
Ondansetron · 2 mg/mL